Arc of a vicious circle: Pathways activated by Mycobacterium tuberculosis that target the HIV-1 long terminal repeat

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 6, 2011, Pages 1116-1124

  Falvo, James V ^a,b   Ranjbar, Shahin ^a,b   Jasenosky, Luke D ^a   Goldfeld, Anne E ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cytokines; HIV TB coinfection; Innate immunity; Signal transduction; Transcription

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6; LECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; VIRUS DNA;

CELL WALL; DNA TRANSCRIPTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 LONG TERMINAL REPEAT; IMMUNE RESPONSE; LONG TERMINAL REPEAT; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TUBERCULOSIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; CYTOKINES; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MYCOBACTERIUM TUBERCULOSIS; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUBERCULOSIS; VIRUS REPLICATION;

EID: 82755174174     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0186TR     Document Type: Review

References (106)

1. Goldfeld AE, Ranjbar S, Tsitsikov EN. Tuberculosis/human immunodeficiency virus coinfection and the host immune response. In: Kaufmann SHE, Britton WJ, editors. Handbook of tuberculosis: immunology and cell biology.Weinheim, Germany: Wiley-VCH; 2008. pp. 347-368.
2. Goldfeld AE, Corbett EL. TB/AIDS coinfection: an integrated clinical and research response. In: Kaufmann SHE, Walker BD, editors. AIDS and tuberculosis: a deadly liaison. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2009. pp. 209-252.
3. Diedrich CR, Flynn JL. HIV-1/Mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun 2011;79:1407-1417.
4. Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011;24:351-376.
5. Coleman CM, Wu L. HIV interactions with monocytes and dendritic cells: viral latency and reservoirs. Retrovirology 2009;6:51.
6. Goldfeld AE, Birch-Limberger K, Schooley RT, Walker BD. HIV-1 infection does not induce tumor necrosis factor-α or interferon-β gene transcription. J Acquir Immune Defic Syndr 1991;4:41-47.
7. Yan N, Lieberman J. Gaining a foothold: how HIV avoids innate immune recognition. Curr Opin Immunol 2011;23:21-28.
8. Shattock RJ, Friedland JS, Griffin GE. Modulation of HIV transcription in and release from human monocytic cells following phagocytosis of Mycobacterium tuberculosis. Res Virol 1993;144:7-12. (Pubitemid 23068327)
9. Zhang Y, Nakata K, Weiden M, Rom WN. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J Clin Invest 1995;95: 2324-2331.
10. Salgame P, Bhatt K, Drage MG, Pecora ND, Harding CV. Mycobacterium tuberculosis interactions with dendritic cells and macrophages. In: Kaufmann SHE, Britton WJ, editors. Handbook of tuberculosis: immunology and cell biology. Weinheim, Germany: Wiley-VCH; 2008. pp. 45-59.
11. Maddocks S, Scandurra GM, Nourse C, Bye C,Williams RB, Slobedman B, Cunningham AL, Britton WJ. Gene expression in HIV-1/ Mycobacterium tuberculosis co-infected macrophages is dominated by M. tuberculosis. Tuberculosis (Edinb) 2009;89:285-293.
12. Peterlin BM, Trono D. Hide, shield and strike back: how HIV-infected cells avoid immune eradication. Nat Rev Immunol 2003;3:97-107. (Pubitemid 37328688)
13. Hakre S, Chavez L, Shirakawa K, Verdin E. Epigenetic regulation of HIV latency. Curr Opin HIV AIDS 2011;6:19-24.
14. Ramírez de Arellano E, Soriano V, Alcamil J, Holguín A. New findings on transcription regulation across different HIV-1 subtypes. AIDS Rev 2006;8:9-16.
15. Kilareski EM, Shah S, Nonnemacher MR, Wigdahl B. Regulation of HIV-1 transcription in cells of the monocyte-macrophage lineage. Retrovirology 2009;6:118.
16. Kuiken C, Foley B, Leitner T, Apetrei C, Hahn B, Mizrachi I, Mullins J, Rambaut A, Wolinsky S, Korber B. HIV Sequence Compendium 2010. Los Alamos, NM: Theoretical Biology and Biphysics Group, Los Alamos National Laboratory; 2010.
17. Perkins ND, Agranoff AB, Pascal E, Nabel GJ. An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol 1994;14:6570-6583. (Pubitemid 24299726)
18. Maniatis T, Falvo JV, Kim TH, Kim TK, Lin CH, Parekh BS, Wathelet MG. Structure and function of the interferon-β enhanceosome. Cold Spring Harb Symp Quant Biol 1998;63:609-620.
19. Falvo JV, Tsytsykova AV, Goldfeld AE. Transcriptional control of the TNF gene. Curr Dir Autoimmun 2010;11:27-60.
20. Tsai EY, Yie J, Thanos D, Goldfeld AE. Cell-type-specific regulation of the human tumor necrosis factor alpha gene in B cells and T cells by NFATp and ATF-2/JUN. Mol Cell Biol 1996;16:5232-5244. (Pubitemid 26315043)
21. Falvo JV, Uglialoro AM, Brinkman BMN, Merika M, Parekh BS, Tsai EY, King HC, Morielli AD, Peralta EG, Maniatis T, et al. Stimulusspecific assembly of enhancer complexes on the tumor necrosis factor alpha gene promoter. Mol Cell Biol 2000;20:2239-2247. (Pubitemid 30123839)
22. Falvo JV, Brinkman BMN, Tsytsykova AV, Tsai EY, Yao T-P, Kung AL, Goldfeld AE. A stimulus-specific role for CREB-binding protein (CBP) in T cell receptor-activated tumor necrosis factor a gene expression. Proc Natl Acad Sci USA 2000;97:3925-3929. (Pubitemid 30226063)
23. Tsai EY, Falvo JV, Tsytsykova AV, Barczak AK, Reimold AM, Glimcher LH, Fenton MJ, Gordon DC, Dunn IF, Goldfeld AE. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo.Mol Cell Biol 2000;20:6084-6094. (Pubitemid 30613056)
24. Tsytsykova AV, Goldfeld AE. Inducer-specific enhanceosome formation controls tumor necrosis factor alpha gene expression in T lymphocytes. Mol Cell Biol 2002;22:2620-2631. (Pubitemid 34262984)
25. Barthel R, Tsytsykova AV, Barczak AK, Tsai EY, Dascher CC, Brenner MB, Goldfeld AE. Regulation of tumor necrosis factor alpha gene expression by mycobacteria involves the assembly of a unique enhanceosome dependent on the coactivator proteins CBP/ p300. Mol Cell Biol 2003;23:526-533. (Pubitemid 36050546)
26. Esensten JH, Tsytsykova AV, Lopez-Rodriguez C, Ligeiro FA, Rao A, Goldfeld AE. NFAT5 binds to the TNF promoter distinctly from NFATp, c, 3 and 4, and activates TNF transcription during hypertonic stress alone. Nucleic Acids Res 2005;33:3845-3854. (Pubitemid 41418554)
27. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011;25: 679-689.
28. Natoli G, Saccani S, Bosisio D, Marazzi I. Interactions of NF-κB with chromatin: the art of being at the right place at the right time. Nat Immunol 2005;6:439-445. (Pubitemid 41716756)
29. Pessler F, Cron RQ. Reciprocal regulation of the nuclear factor of activated T cells and HIV-1. Genes Immun 2004;5:158-167. (Pubitemid 38967647)
30. Falvo JV, Lin CH, Tsytsykova AV, Hwang PK, Thanos D, Goldfeld AE, Maniatis T. A dimer-specific function of the transcription factor NFATp. Proc Natl Acad Sci USA 2008;105:19637-19642.
31. Bates DL, Barthel KK, Wu Y, Kalhor R, Stroud JC, Giffin MJ, Chen L. Crystal structure of NFAT bound to the HIV-1 LTR tandem kB enhancer element. Structure 2008;16:684-694. (Pubitemid 351615017)
32. Ranjbar S, Tsytsykova AV, Lee SK, Rajsbaum R, Falvo JV, Lieberman J, Shankar P, Goldfeld AE. NFAT5 regulates HIV-1 in primary monocytes via a highly conserved long terminal repeat site. PLoS Pathog 2006;2:e130.
33. Shaulian E. AP-1-The Jun proteins: oncogenes or tumor suppressors in disguise? Cell Signal 2010;22:894-899.
34. Henderson AJ, Calame KL. CCAAT/enhancer binding protein (C/ EBP) sites are required for HIV-1 replication in primary macrophages but not CD41 T cells. Proc Natl Acad Sci USA 1997;94:8714-8719. (Pubitemid 27335105)
35. Weiden M, Tanaka N, Qiao Y, Zhao BY, Honda Y, Nakata K, Canova A, Levy DE, Rom WN, Pine R. Differentiation of monocytes to macrophages switches the Mycobacterium tuberculosis effect on HIV-1 replication from stimulation to inhibition: modulation of interferon response and CCAAT/enhancer binding protein b expression. J Immunol 2000;165:2028-2039. (Pubitemid 30643152)
36. Hoshino Y, Nakata K, Hoshino S, Honda Y, Tse DB, Shioda T, Rom WN, Weiden M. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J Exp Med 2002;195:495-505. (Pubitemid 34461302)
37. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010;11:373-384.
38. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, Fenton MJ. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J Immunol 1999;163:3920-3927. (Pubitemid 29450920)
39. Bulut Y, Michelsen KS, Hayrapetian L, Naiki Y, Spallek R, Singh M, Arditi M. Mycobacterium tuberculosis heat shock proteins use diverse Toll-like receptor pathways to activate pro-inflammatory signals. J Biol Chem 2005;280:20961-20097.
40. Jung SB, Yang CS, Lee JS, Shin AR, Jung SS, Son JW, Harding CV, Kim HJ, Park JK, Paik TH, et al. The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytes. Infect Immun 2006; 74:2686-2696. (Pubitemid 43672977)
41. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005; 202:1715-1724. (Pubitemid 41815877)
42. Ito T, Schaller M, Hogaboam CM, Standiford TJ, Chensue SW, Kunkel SL. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur J Immunol 2007;37:2847-2855. (Pubitemid 47578304)
43. Harding CV, Boom WH. Regulation of antigen presentation by Mycobacterium tuberculosis: a role for Toll-like receptors. Nat Rev Microbiol 2010;8:296-307.
44. Vallabhapurapu S, Karin M. Regulation and function of NF-κB transcription factors in the immune system. Annu Rev Immunol 2009;27: 693-733.
45. Pennini ME, Liu Y, Yang J, Croniger CM, Boom WH, Harding CV. CCAAT/enhancer-binding protein β and δ binding to CIITA promoters is associated with the inhibition of CIITA expression in response to Mycobacterium tuberculosis 19-kDa lipoprotein. J Immunol 2007;179:6910-6918.
46. El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao- Tamayo M, Basaraba RJ, Konig T, Schleicher U, Koo MS, et al. Tolllike receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat Immunol 2008;9:1399-1406.
47. Sow FB, Alvarez GR, Gross RP, Satoskar AR, Schlesinger LS, Zwilling BS, Lafuse WP. Role of STAT1, NF-κB, and C/EBPβ in the macrophage transcriptional regulation of hepcidin by mycobacterial infection and IFN-γ. J Leukoc Biol 2009;86:1247-1258.
48. Lu YC, Kim I, Lye E, Shen F, Suzuki N, Suzuki S, Gerondakis S, Akira S, Gaffen SL, Yeh WC, et al. Differential role for c-Rel and C/EBPβ/δ in TLR-mediated induction of proinflammatory cytokines. J Immunol 2009;182:7212-7221.
49. Pandey AK, Yang Y, Jiang Z, Fortune SM, Coulombe F, Behr MA, Fitzgerald KA, Sassetti CM, Kelliher MA. NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis. PLoS Pathog 2009;5:e1000500.
50. Underhill DM, Shimada T. A pair of 9s: it's in the CARDs. Nat Immunol 2007;8:122-124. (Pubitemid 46152640)
51. Ferwerda G, Girardin SE, Kullberg BJ, Le Bourhis L, de Jong DJ, Langenberg DM, van Crevel R, Adema GJ, Ottenhoff THM, Van der Meer JWM, et al. NOD2 and toll-like receptors are nonredundant recognition systems of Mycobacterium tuberculosis. PLoS Pathog 2005;1:279-285.
52. Yang Y, Yin C, Pandey A, Abbott D, Sassetti C, Kelliher MA. NOD2 pathway activation by MDP or Mycobacterium tuberculosis infection involves the stable polyubiquitination of Rip2. J Biol Chem 2007;282: 36223-36229.
53. Neyrolles O, Gicquel B, Quintana-Murci L. Towards a crucial role for DC-SIGN in tuberculosis and beyond. Trends Microbiol 2006;14: 383-387. (Pubitemid 44233297)
54. Korbel DS, Schneider BE, Schaible UE. Innate immunity in tuberculosis: myths and truth. Microbes Infect 2008;10:995-1004.
55. Geijtenbeek TB, Gringhuis SI. Signalling through C-type lectin receptors: shaping immune responses. Nat Rev Immunol 2009;9:465-479.
56. Torrelles JB, Schlesinger LS. Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) 2010;90:84-93.
57. Ehlers S. DC-SIGN and mannosylated surface structures of Mycobacterium tuberculosis: a deceptive liaison. Eur J Cell Biol 2010;89:95-101.
58. van de Veerdonk FL, Teirlinck AC, Kleinnijenhuis J, Kullberg BJ, van Crevel R, van der Meer JW, Joosten LA, Netea MG. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol 2010; 88:227-232.
59. Keane J, Bresnihan B. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies. Curr Opin Rheumatol 2008;20:443-449.
60. Salgame P. Host innate and Th1 responses and the bacterial factors that control Mycobacterium tuberculosis infection. Curr Opin Immunol 2005;17:374-380. (Pubitemid 40848539)
61. Quesniaux VF, Jacobs M, Allie N, Grivennikov S, Nedospasov SA, Garcia I, Olleros ML, Shebzukhov Y, Kuprash D, Vasseur V, et al. TNF in host resistance to tuberculosis infection. Curr Dir Autoimmun 2010;11:157-179.
62. Collins KR, Quiñones-Mateu ME, Toossi Z, Arts EJ. Impact of tuberculosis on HIV-1 replication, diversity, and disease progression. AIDS Rev 2002;4:165-176. (Pubitemid 35251994)
63. Ranjbar S, Boshoff HI, Mulder A, Siddiqi N, Rubin EJ, Goldfeld AE. HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS ONE 2009;4:e6116.
64. + T cell expansion and increased IL-10 levels. J Immunol 2004;172:1953-1959.
65. Tsytsykova AV, Falvo JV, Schmidt-Supprian M, Courtois G, Thanos D, Goldfeld AE. Post-induction, stimulus-specific regulation of tumor necrosis factor mRNA expression. J Biol Chem 2007;282:11629-11638. (Pubitemid 47100663)
66. Bianchi K, Meier P. A tangled web of ubiquitin chains: breaking news in TNF-R1 signaling. Mol Cell 2009;36:736-742.
67. Reiling N, Ehlers S, Hölscher C. MyDths and un-TOLLed truths: sensor, instructive and effector immunity to tuberculosis. Immunol Lett 2008;116:15-23.
68. Kedzierska K, Crowe SM. Cytokines and HIV-1: interactions and clinical implications. Antivir Chem Chemother 2001;12:133-150. (Pubitemid 32963913)
69. Zhang Y, Broser M, Rom WN. Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-κB. Proc Natl Acad Sci USA 1994;91: 2225-2229. (Pubitemid 24092076)
70. Auron PE, Webb AC. Interleukin-1: a gene expression system regulated at multiple levels. Eur Cytokine Netw 1994;5:573-592.
71. Moynagh PN. The Pellino family: IRAK E3 ligases with emerging roles in innate immune signalling. Trends Immunol 2009;30:33-42.
72. Dinarello CA. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 2009;27:519-550.
73. Bretz JD, Williams SC, Baer M, Johnson PF, Schwartz RC. C/EBP-related protein 2 confers lipopolysaccharide-inducible expression of interleukin 6 and monocyte chemoattractant protein 1 to a lymphoblastic cell line. Proc Natl Acad Sci USA 1994;91:7306-7310. (Pubitemid 24226852)
74. Hu HM, Baer M, Williams SC, Johnson PF, Schwartz RC. Redundancy of C/EBP α, -β, and -δ in supporting the lipopolysaccharide-induced transcription of IL-6 and monocyte chemoattractant protein-1. J Immunol 1998;160:2334-2342. (Pubitemid 28119915)
75. Ping D, Boekhoudt G, Zhang F, Morris A, Philipsen S, Warren ST, Boss JM. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J Biol Chem 2000;275: 1708-1714. (Pubitemid 30060790)
76. Boekhoudt GH, Guo Z, Beresford GW, Boss JM. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J Immunol 2003;170:4139-4147. (Pubitemid 36428178)
77. Teferedegne B, Green MR, Guo Z, Boss JM. Mechanism of action of a distalNF-κB-dependent enhancer. Mol Cell Biol 2006;26:5759-5770.
78. Melgarejo E, Medina MA, Saaposnchez-Jimeaposnez F, Urdiales JL. Monocyte chemoattractant protein-1: a key mediator in inflammatory processes. Int J Biochem Cell Biol 2009;41:998-1001.
79. Fietta AM, Morosini M, Meloni F, Bianco AM, Pozzi E. Pharmacological analysis of signal transduction pathways required for Mycobacterium tuberculosis-induced IL-8 and MCP-1 production in human peripheral monocytes. Cytokine 2002;19:242-249. (Pubitemid 35257824)
80. Ogawa T, Uchida H, Kusumoto Y, Mori Y, Yamamura Y, Hamada S. Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis. Infect Immun 1991;59:3021-3025.
81. Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci AS. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and post-transcriptional mechanisms. J Exp Med 1990;172:151-158. (Pubitemid 20217256)
82. Seshadri S, Kannan Y, Mitra S, Parker-Barnes J, Wewers MD. MAIL regulates human monocyte IL-6 production. J Immunol 2009;183: 5358-5368.
83. Wang X, Lupardus P, Laporte SL, Garcia KC. Structural biology of shared cytokine receptors. Annu Rev Immunol 2009;27:29-60.
84. Fischer P, Hilfiker-Kleiner D. Survival pathways in hypertrophy and heart failure: the gp130-STAT axis. Basic Res Cardiol 2007;102:393-411. (Pubitemid 47278812)
85. Nakajima T, Kinoshita S, Sasagawa T, Sasaki K, Naruto M, Kishimoto T, Akira S. Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6. Proc Natl Acad Sci USA 1993;90:2207-2211. (Pubitemid 23078595)
86. Lee S, Shuman JD, Guszczynski T, Sakchaisri K, Sebastian T, Copeland TD, Miller M, Cohen MS, Taunton J, Smart RC, et al. RSKmediated phosphorylation in the C/EBPβ leucine zipper regulates DNA binding, dimerization, and growth arrest activity. Mol Cell Biol 2010;30:2621-2635.
87. Roberts AB, Kim S-J, Noma T, Glick AB, Lafyatis R, Lechleider R, Jakowlew SB, Geiser A, O'Reilly MA, Danielpour D, et al. Multiple forms of TGF-β: distinct promoters and differential expression. Ciba Found Symp 1991;157:7-15, discussion 15-28.
88. Toossi Z, Gogate P, Shiratsuchi H, Young T, Ellner JJ. Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lung lesions. J Immunol 1995;154:465-473.
89. Li J-M, Shen X, Hu PP-C, Wang X-F. Transforming growth factor β stimulates the human immunodeficiency virus 1 enhancer and requires NF-kB activity. Mol Cell Biol 1998;18:110-121. (Pubitemid 28021023)
90. Abraham S, Sweet T, Khalili K, Sawaya BE, Amini S. Evidence for activation of the TGF-β1 promoter by C/EBPβ and its modulation by Smads. J Interferon Cytokine Res 2009;29:1-7.
91. Coyle-Rink J, Sweet T, Abraham S, Sawaya B, Batuman O, Khalili K, Amini S. Interaction between TGFβ signaling proteins and C/EBP controls basal and Tat-mediated transcription of HIV-1 LTR in astrocytes. Virology 2002;299:240-247. (Pubitemid 35356600)
92. Moriuchi M, Moriuchi H. Cell-type-dependent effect of transforming growth factor β, a major cytokine in breast milk, on human immunodeficiency virus type 1 infection of mammary epithelial MCF- 7 cells or macrophages. J Virol 2004;78:13046-13052. (Pubitemid 39507812)
93. Landström M. The TAK1-TRAF6 signalling pathway. Int J Biochem Cell Biol 2010;42:585-589.
94. Warfel AH, Thorbecke GJ, Belsito DV. Synergism between interferonγ and cytokines or lipopolysaccharide in the activation of the HIVLTR in macrophages. J Leukoc Biol 1995;57:469-476.
95. Ottenhoff THM, Verreck FAW, Hoeve MA, van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb) 2005;85:53-64. (Pubitemid 40431316)
96. Sun D, Ding A. MyD88-mediated stabilization of interferon-γ-induced cytokine and chemokine mRNA. Nat Immunol 2006;7:375-381.
97. Kalvakolanu DV, Roy SK. CCAAT/enhancer binding proteins and interferon signaling pathways. J Interferon Cytokine Res 2005;25: 757-769. (Pubitemid 43068487)
98. Li H, Gade P, Nallar SC, Raha A, Roy SK, Karra S, Reddy JK, Reddy SP, Kalvakolanu DV. The Med1 subunit of transcriptional mediator plays a central role in regulating CCAAT/enhancer-binding proteinß- driven transcription in response to interferon-γ. J Biol Chem 2008; 283:13077-13086.
99. Comas I, Gagneux S. The past and future of tuberculosis research. PLoS Pathog 2009;5:e1000600.
100. Manca C, Tsenova L, Barry CE III, Bergtold A, Freeman S, Haslett PA, Musser JM, Freedman VH, Kaplan G. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 1999;162:6740-6746. (Pubitemid 29309400)
101. Manca C, Tsenova L, Bergtold A, Freeman S, Tovey M, Musser JM, Barry CE III, Freedman VH, Kaplan G. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFNα/β. Proc Natl Acad Sci USA 2001;98:5752-5757. (Pubitemid 32435714)
102. Reed MB, Domenech P, Manca C, Su H, Barczak AK, Kreiswirth BN, Kaplan G, Barry CE III. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 2004;431: 84-87. (Pubitemid 39215112)
103. Balcewicz-Sablinska MK, Keane J, Kornfeld H, Remold HG. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-α. J Immunol 1998;161:2636-2641. (Pubitemid 28397084)
104. Triantafilou M, Morath S, Mackie A, Hartung T, Triantafilou K. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J Cell Sci 2004; 117:4007-4014. (Pubitemid 39207336)
105. Rocha-Ramírez LM, Estrada-García I, López-Marin LM, Segura- Salinas E, Méndez-Aragón P, Van Soolingen D, Torres-González R, Chacón-Salinas R, Estrada-Parra S, Maldonado-Bernal C, et al. Mycobacterium tuberculosis lipids regulate cytokines, TLR-2/4 and MHC class II expression in human macrophages. Tuberculosis (Edinb) 2008;88:212-220.
106. Jeeninga RE, Hoogenkamp M, Armand-Ugon M, de Baar M, Verhoef K, Berkhout B. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J Virol 2000;74:3740-3751. (Pubitemid 30180317)